These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 2114821)

  • 1. In vitro cytotoxicity of hexamethylmelamine (HMM) and its derivatives.
    Dubois J; Arnould R; Abikhalil F; Hanocq M; Atassi G; Ghanem G; Libert A; Lejeune FJ
    Anticancer Res; 1990; 10(3):827-32. PubMed ID: 2114821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Compared cytotoxicity effects of five anticancer drugs on human (HBL) and mouse (B16) melanoma cells in vitro.
    Arnould R; Dubois J; Abikhalil F; Libert A; Ghanem G; Atassi G; Hanocq M; Lejeune FJ
    Anticancer Res; 1990; 10(3):789-93. PubMed ID: 2369092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor pharmacokinetics of hexamethylmelamine in CDF1 mice bearing P388 leukemia.
    Dubois J; Atassi G; Hanocq M; Abikhalil F
    Anticancer Res; 1989; 9(1):255-9. PubMed ID: 2495757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro cytotoxicity of imidazolyl-1,3,5-triazine derivatives.
    Yaguchi S; Izumisawa Y; Sato M; Nakagane T; Koshimizu I; Sakita K; Kato M; Yoshioka K; Sakato M; Kawashima S
    Biol Pharm Bull; 1997 Jun; 20(6):698-700. PubMed ID: 9212994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of DNA damage by methylmelamines and formaldehyde.
    Ross WE; McMillan DR; Ross CF
    J Natl Cancer Inst; 1981 Jul; 67(1):217-21. PubMed ID: 6788992
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of two cytotoxicity assays--tetrazolium derivative reduction (MTT) and tritiated thymidine uptake--on three malignant mouse cell lines using chemotherapeutic agents and investigational drugs.
    Arnould R; Dubois J; Abikhalil F; Libert A; Ghanem G; Atassi G; Hanocq M; Lejeune FJ
    Anticancer Res; 1990; 10(1):145-54. PubMed ID: 2334120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro cytotoxicity of the methylmelamines.
    Rutty CJ; Abel G
    Chem Biol Interact; 1980 Feb; 29(2):235-46. PubMed ID: 6766359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Time dependence of the in vitro cytotoxicity of hexamethylmelamine and its metabolites.
    D'Incalci M; Erba E; Balconi G; Morasca L; Garattini S
    Br J Cancer; 1980 Apr; 41(4):630-5. PubMed ID: 6770884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics and metabolism of hexamethylmelamine in mice bearing renal cell tumors.
    Dubois J; Atassi G; Hanocq M; Abikhalil F
    Cancer Chemother Pharmacol; 1988; 22(4):282-8. PubMed ID: 3139314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A newly developed hexamethylmelamine derivative, SAE9 with both antitumor and aromatase-inhibitory activity.
    Tanino H; Kubota T; Yamada Y; Koh JI; Takeuchi T; Kase S; Furukawa T; Takahashi M; Fukuda S; Ogose N
    Anticancer Res; 1993; 13(3):623-6. PubMed ID: 8317890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies of the mode of action of antitumour triazenes and triazines-V. The correlation of the in vitro cytotoxicity and in vivo antitumour activity of hexamethylmelamine analogues with their metabolism.
    Ross D; Langdon SP; Gescher A; Stevens MF
    Biochem Pharmacol; 1984 Apr; 33(7):1131-6. PubMed ID: 6424683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative pharmacology of pentamethylmelamine and hexamethylmelamine in mice.
    Morimoto M; Green D; Rahman A; Goldin A; Schein PS
    Cancer Res; 1980 Aug; 40(8 Pt 1):2762-7. PubMed ID: 6771004
    [No Abstract]   [Full Text] [Related]  

  • 13. Antitumor activity of hexamethylmelamine on human tumor xenografts serially transplanted in nude mice.
    Kubota T; Tanino H; Watanabe M; Kitajima M
    Anticancer Res; 1994; 14(6B):2521-4. PubMed ID: 7872676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics and metabolism of hexamethylmelamine in mice after IP administration.
    Dubois J; Atassi G; Hanocq M; Abikhalil F
    Cancer Chemother Pharmacol; 1986; 18(3):226-30. PubMed ID: 3100080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Structure-activity relationship of hexamethylmelamine derivatives].
    Su YZ; Pan QC; Sun MZ; Ren YF
    Zhongguo Yao Li Xue Bao; 1983 Dec; 4(4):276-80. PubMed ID: 6230876
    [No Abstract]   [Full Text] [Related]  

  • 16. DNA topoisomerase II-mediated interaction of doxorubicin and daunorubicin congeners with DNA.
    Bodley A; Liu LF; Israel M; Seshadri R; Koseki Y; Giuliani FC; Kirschenbaum S; Silber R; Potmesil M
    Cancer Res; 1989 Nov; 49(21):5969-78. PubMed ID: 2551497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of hexamethylmelamine and pentamethylmelamine in mice.
    Broggini M; Colombo T; D'Incalci M; Donnelli MG; Gescher A; Garattini S
    Cancer Treat Rep; 1981; 65(7-8):669-72. PubMed ID: 6788370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of phenobarbital pretreatment on the metabolism and antitumor activity of hexamethylmelamine.
    Paolini A; D'Incalci M
    Cancer Treat Rep; 1986 Apr; 70(4):513-6. PubMed ID: 3084083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytotoxicity of alkyl-lysophospholipid derivatives and low-alkyl-cleavage enzyme activities in rat brain tumor cells.
    Berdel WE; Greiner E; Fink U; Stavrou D; Reichert A; Rastetter J; Hoffman DR; Snyder F
    Cancer Res; 1983 Feb; 43(2):541-5. PubMed ID: 6848177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of a hepatic activation system on the antiproliferative activity of hexamethylmelamine against human tumor cell lines.
    Miller KJ; McGovern RM; Ames MM
    Cancer Chemother Pharmacol; 1985; 15(1):49-53. PubMed ID: 3924426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.